AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Heinonen, H Volin, L Uutela, A Zevon, M Barrick, C Ruutu, T
Citation: H. Heinonen et al., Quality of life and factors related to perceived satisfaction with qualityof life after allogeneic bone marrow transplantation, ANN HEMATOL, 80(3), 2001, pp. 137-143

Authors: Heinonen, H Volin, L Uutela, A Zevon, M Barrick, C Ruutu, T
Citation: H. Heinonen et al., Gender-associated differences in the quality of life after allogeneic BMT, BONE MAR TR, 28(5), 2001, pp. 503-509

Authors: Bjorkstrand, B Svensson, H Goldschmidt, H Ljungman, P Apperley, J Mandelli, F Marcus, R Boogaerts, M Alegre, A Remes, K Cornelissen, JJ Blade, J Lenhoff, S Iriondo, A Carlson, K Volin, L Littlewood, T Goldstone, AH San Miguel, J Schattenberg, A Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515

Authors: Parkkali, T Kayhty, H Lehtonen, H Ruutu, T Volin, L Eskola, J Ruutu, P
Citation: T. Parkkali et al., Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients, BONE MAR TR, 27(1), 2001, pp. 79-84

Authors: Gahrton, G Svensson, H Cavo, M Apperley, J Bacigalupo, A Bjorkstrand, B Blade, J Cornelissen, J de Laurenzi, A Facon, T Ljungman, P Michallet, M Niederwieser, D Powles, R Reiffers, J Russell, NH Samson, D Schaefer, UW Schattenberg, A Tura, S Verdonck, LF Vernant, JP Willemze, R Volin, L
Citation: G. Gahrton et al., Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres, BR J HAEM, 113(1), 2001, pp. 209-216

Authors: Oivanen, T Ala-Harja, K Almqvist, A Apajalahti, J Elonen, E Hallman, H Hanninen, A Ilvonen, M Isomaa, B Jouppila, J Jarvenpaa, E Jarventie, G Kilpi, H Koistinen, P Koistinen, S Koivisto, AM Koivunen, E Korpi, E Katka, K Kaariainen, M Lahtinen, R Laitinen, A Lehtinen, M Makela, H Nylanden, P Nyman, D Palva, I Pelliniemi, TT Pulli, T Rajamaki, A Rauhala, A Remes, K Rosengard, S Ruutu, T Soininen, K Tiilikainen, J Timonen, T Waris, E Vilpo, J Volin, L
Citation: T. Oivanen et al., Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study, EUR J HAEMA, 65(2), 2000, pp. 123-127

Authors: Jantunen, E Ruutu, P Piilonen, A Volin, L Parkkali, T Ruutu, T
Citation: E. Jantunen et al., Treatment and outcome of invasive Aspergillus infections in allogeneic BMTrecipients, BONE MAR TR, 26(7), 2000, pp. 759-762

Authors: Jantunen, E Piilonen, A Volin, L Parkkali, T Koukila-Kahkola, P Ruutu, T Ruutu, P
Citation: E. Jantunen et al., Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients, BONE MAR TR, 25(8), 2000, pp. 867-871

Authors: Ruutu, T Volin, L Parkkali, T Juvonen, E Elonen, E
Citation: T. Ruutu et al., Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study, BLOOD, 96(7), 2000, pp. 2391-2398

Authors: Gahrton, G Svensson, H Bjorkstrand, B Apperley, J Carlson, K Cavo, M Ferrant, A Fouillard, L Gratecos, N Gratwohl, A Guilhot, F Deliliers, GL Ljungman, P Masszi, T Milligan, DW Powles, RL Reiffers, J Samson, JD Stoppa, AM Vernant, JP Volin, L Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745

Authors: Parkkali, T Kayhty, H Antilla, M Ruutu, T Wuorimaa, T Soininen, A Volin, L Ruutu, P
Citation: T. Parkkali et al., IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines, BONE MAR TR, 24(6), 1999, pp. 671-678

Authors: Valimaki, MJ Kinnunen, K Volin, L Tahtela, R Loyttyniemi, E Laitinen, K Makela, P Keto, P Ruutu, T
Citation: Mj. Valimaki et al., A prospective study of bone loss and turnover after allogeneic bone marrowtransplantation: effect of calcium supplementation with or without calcitonin, BONE MAR TR, 23(4), 1999, pp. 355-361

Authors: Juvonen, E Aimolahti, A Volin, L Ruutu, T
Citation: E. Juvonen et al., The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes, LEUK RES, 23(10), 1999, pp. 889-894

Authors: Oivanen, T Ala-Harja, K Almqvist, A Apajalahti, J Elonen, E Hallman, H Hanninen, A Ilvonen, M Isomaa, B Jouppila, J Jarvenpaa, E Jarventie, G Kilpi, H Koistinen, P Koistinen, S Koivisto, AM Koivunen, E Korpi, E Katka, K Kaariainen, M Lahtinen, R Laitinen, A Lehtinen, M Makela, H Nylanden, P Nyman, D Palva, I Pelliniemi, TT Pulli, T Rajamaki, A Rauhala, A Remes, K Rosengard, S Ruutu, T Soininen, K Tiilikainen, J Timonen, T Waris, E Vilpo, J Volin, L
Citation: T. Oivanen et al., Long-term survival in multiple myeloma: a Finnish Leukaemia Group study, BR J HAEM, 105(4), 1999, pp. 942-947

Authors: Ringden, O Remberger, M Ruutu, T Nikoskelainen, J Volin, L Vindelov, L Parkkali, T Lenhoff, S Sallerfors, B Mellander, L Ljungman, P Jacobsen, N
Citation: O. Ringden et al., Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia, BLOOD, 93(7), 1999, pp. 2196-2201
Risultati: 1-15 |